These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38854245)

  • 21. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
    Delyon J; Ortonne N; Benayoun E; Moroch J; Wolkenstein P; Sbidian E; Chosidow O
    J Am Acad Dermatol; 2015 Sep; 73(3):484-90. PubMed ID: 26190242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
    Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction.
    Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Rheumatol Int; 2020 May; 40(5):765-770. PubMed ID: 32170389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Wrong administration of methotrexate can lead to fatal haematological complications in elderly patients].
    Christensen AM; Thagaard MS; Stentoft J
    Ugeskr Laeger; 2013 Feb; 175(7):435-6. PubMed ID: 23402255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
    Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
    Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancytopenia after accidental overdose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis.
    Brown MA; Corrigan AB
    Med J Aust; 1991 Oct; 155(7):493-4. PubMed ID: 1921823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
    Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
    J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients.
    Wollina U; Ständer K; Barta U
    Clin Rheumatol; 2001; 20(6):406-10. PubMed ID: 11771523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication Error- A Case Report of Misadventure with Methotrexate.
    Singh A; Handa AC
    JNMA J Nepal Med Assoc; 2018; 56(211):711-715. PubMed ID: 30381772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serious complications during treatment with methotrexate: also in chronic low-dosage use].
    Rodenburg RJ; Wijnands MJ; Rensma PL
    Ned Tijdschr Geneeskd; 2017; 161():D575. PubMed ID: 28120731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.
    Manappallil RG; Prasan D; Peringat J; Biju IK
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29871962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature.
    Koutsompina ML; Pappa M; Sakellariou S; Gialouri CG; Fragoulis GE; Androutsakos T
    Mediterr J Rheumatol; 2021 Sep; 32(3):264-272. PubMed ID: 34964031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancytopenia Due to Possible Drug-Drug Interactions Between Low-Dose Methotrexate and Proton Pump Inhibitors.
    Tao D; Wang H; Xia F; Ma W
    Drug Healthc Patient Saf; 2022; 14():75-78. PubMed ID: 35607639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
    Ferguson NN; Asarch A; VanBeek M; Swick BL
    Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Methotrexate Toxicity Due to Overdosing in Psoriasis: A Series of Seven Cases.
    Pradhan S; Sirka CS; Rout AN; Dash G; Sahu K
    Indian Dermatol Online J; 2019; 10(1):64-68. PubMed ID: 30775303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.
    Montaudié H; Sbidian E; Paul C; Maza A; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():12-8. PubMed ID: 21388454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute methotrexate toxicity in a patient with psoriasis: a case report.
    Abouzahir H; Belhouss A; Benyaich H
    Pan Afr Med J; 2024; 47():19. PubMed ID: 38524110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe methotrexate toxicity in elderly patients under diuretics.
    Kumar C; Kuhn M; Herrmann K; Leuchten N; Aringer M
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38176739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.